Clinical Trial Update: Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections: N-Acetylcysteine [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating an individualized multiplex pathophysiological treatment using N-acetylcysteine for severe acute infections, including sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Theis S. Itenov | Conditions: Sepsis, Acute Infection | Phase 4 | Status: NOT_YET_RECRUITING